S2Medical AB (S2M) — Capital Reinvestment Ratio
S2Medical AB (S2M) has a Capital Reinvestment Ratio of 0.78x as of June 2025, meaning it reinvests 1% of its operating cash flow (Skr1.29 Million) in capital expenditures (Skr1.01 Million). Check S2Medical AB tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
S2Medical AB Capital Reinvestment Ratio (2024–2025)
This chart tracks S2Medical AB's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see S2M cash flow conversion.
Annual Capital Reinvestment Ratio for S2Medical AB (2024–2025)
Year-by-year Capital Reinvestment Ratio for S2Medical AB from 2024 to 2025. See S2Medical AB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | ▲ +693.5% |
| 2024 | 0.13x | Skr5.03 Million | Skr634.00K | — |